📍 17009 Pines Blvd, Pembroke Pines, FL  |  Serving Florida Residents Exclusively (954) 799-6439
Weight Loss · Pembroke Pines, FL

Retatrutide Weight Loss
in Pembroke Pines, FL

Retatrutide (sometimes called "Reta" or "Reta peptide") is a newer, prescription injectable medication used for medical weight loss and metabolic health. It activates three hormone receptors simultaneously — delivering results beyond what single or dual-action medications can achieve.

Retatrutide for weight loss is still an investigational medication and is not yet approved by the FDA for routine clinical use. Much of the data comes from trials conducted by Eli Lilly and Company, published in The New England Journal of Medicine.

🏆
24–28%
Average Total Body Weight Loss Reported
82%
Patients Achieving >15% Reduction
86%
Reduction in Liver Fat (Early Studies)
Hormone Receptors Activated (GGG)
Retatrutide weight loss Miami
Physician-Supervised Treatment
Overview

What is Retatrutide and How Does It Work?

Retatrutide is a prescription injectable medication given as a weekly subcutaneous shot — similar to other weight-loss injections — and is meant to be used as part of a medically supervised plan.

Because it's still relatively new, access and eligibility can vary. People only receive it from a medical provider who first reviews their health history and current medications, ensuring it's an appropriate and safe option.

💉
Once-Weekly Injection
Administered as a subcutaneous shot under the skin, using a dose-escalation approach for better tolerability.
🔬
Triple-Receptor Action
Activates GLP-1, GIP, and glucagon receptors simultaneously — uniquely targeting appetite, insulin, and energy burn.
🩺
Physician-Led Program
Requires medical review of health history and regular follow-ups to ensure safe, structured progress.
The Science

Retatrutide Triple Hormone Receptor Agonist (GGG)

Retatrutide is often called a “triple agonist” because it activates three different hormone receptors that help regulate appetite, blood sugar, and metabolism: GLP-1, GIP, and glucagon.

GLP-1
Glucagon-Like Peptide-1

GLP-1 is a natural “after-meal” hormone. When GLP-1 receptors are activated, the brain gets stronger fullness signals, the stomach empties more slowly (so you stay full longer), and the pancreas releases insulin in a glucose-dependent way (more support when blood sugar is higher). That combination is a big reason GLP-1 medicines tend to reduce appetite.

GIP
Glucose-Dependent Insulinotropic Peptide

GIP is another incretin hormone that also supports insulin release after meals. GIP activation may improve insulin sensitivity (how well your cells respond to insulin), which can help the body handle carbs more smoothly.

Glucagon
Glucagon Receptor

Glucagon is best known for raising blood sugar. Still, it also has effects tied to higher energy use, including supporting “calorie burn at rest” through metabolic pathways in the liver and other tissues. The idea behind pairing glucagon activity with GLP-1/GIP is to boost energy expenditure while GLP-1/GIP help keep appetite and glucose control in check.

Why It Works

Benefits of Retatrutide Weight Loss Injection

Once-Weekly Subcutaneous Injection. In studies, retatrutide for weight loss has been given as a once-weekly injection under the skin, using a dose-escalation approach to improve tolerability.

Request a Consultation
01
Triple-Action Mechanism (GLP-1, GIP, and Glucagon)
Retatrutide is designed to act on three hormone receptors involved in appetite, blood sugar regulation, and energy use.
02
Substantial Weight Loss
Higher-dose groups have reported (alternate source) (alternate source 2) average retatrutide weight loss around the mid-20% range over about a year, with longer studies reporting results approaching the high-20% range. (Results vary by dose, time on retatrutide treatment, and individual factors.)
Up to 24–28% total body weight
03
High Success Rate
In a 48-week study, approximately 83% of participants on the highest dose lost at least 15% of their starting body weight — a remarkable clinical benchmark.
82% of patients achieve >15% reduction
04
Increased Energy Expenditure & Fat Metabolism
The glucagon-receptor part of the retatrutide weight loss injection is intended to increase “energy expenditure,” meaning your body may burn more calories at rest and rely more on stored energy.
05
Significant Reduction in Liver Fat
Early studies also suggest large reductions in liver fat on imaging in some people, which is why retatrutide is being explored for metabolic conditions beyond weight.
Up to 86% liver fat reduction
06
Improved Metabolic Markers
Weight loss aside, researchers have reported improvements in several cardiometabolic measures (the kinds of numbers clinicians track for long-term health).
07
Reduced "Food Noise" & Increased Satiety
It may help have fewer intrusive food thoughts and feel full sooner; this aligns with how GLP-1/GIP signaling influences appetite and fullness.
08
Enhanced Muscle Preservation
Any significant weight loss can involve some lean-mass loss, so preserving muscle usually depends on the full plan, which typically includes adequate protein, resistance training, and close medical guidance as weight comes down.
Comparison

Retatrutide vs. Other Weight Loss Medications

See how retatrutide stacks up against semaglutide and tirzepatide — the leading GLP-1 medications — in terms of mechanism and average weight loss outcomes.

Medication Mechanism Study Duration Avg. Weight Loss Notable Feature
Semaglutide (Wegovy) GLP-1 agonist 68 weeks ~14.9% FDA-approved; strong safety profile
Tirzepatide (Zepbound) GLP-1 + GIP dual agonist 72 weeks 15.0–20.9% Dual receptor; FDA-approved for obesity
Retatrutide (Reta) GLP-1 + GIP + Glucagon (triple) 48 weeks 22.8–24.2% Highest reported weight loss; investigational
Why the Triple Agonist Advantage? A plateau is common in weight loss, even with medication. Retatrutide's "extra" piece — the glucagon receptor — may help the body use more energy even at rest. GLP-1 addresses appetite control, GIP supports insulin sensitivity, and glucagon fights the metabolic slowdown. Together, they target both sides of the plateau problem simultaneously.
Who Qualifies

Candidates for Retatrutide Treatment

Our physicians perform a comprehensive health review before recommending retatrutide. Here's who typically qualifies — and who may not be eligible.

Who Is a Good Candidate
  • Adults with obesity (BMI 30+) — Often considered when weight is affecting health or daily life.
  • Overweight with comorbidities (BMI 27+) — Including high blood pressure or high cholesterol tied to medical risk factors.
  • Patients with weight-related conditions — Sleep apnea, osteoarthritis, and cardiovascular disease may all be impacted by excess weight.
  • Individuals with metabolic dysfunction — Conditions like NAFLD/MASLD or chronic kidney disease may be part of the discussion.
  • People who plateaued on Wegovy or Zepbound — Some patients stop losing after early progress and require a plan adjustment.
  • Those seeking non-surgical bariatric-style results — For people who prefer to avoid surgery and have realistic expectations.
  • Individuals struggling with "food noise" and cravings — Constant food thoughts or cravings that feel hard to control.
Exclusions & Contraindications
  • Type 1 diabetes — Reta-peptide research is focused on obesity and metabolic disease, not insulin replacement.
  • History of pancreatitis — Many programs avoid incretin-based therapies in patients with prior pancreatitis due to safety concerns.
  • Personal or family history of medullary thyroid carcinoma (MTC) — A major red flag for this medication class.
  • Multiple Endocrine Neoplasia type 2 (MEN-2) — Another key exclusion tied to thyroid tumor risk.
  • Recent significant weight change (>5 kg in 90 days) — A big recent change makes it difficult to assess baseline health and response.
  • Pregnancy, breastfeeding, or planning to conceive — Generally avoided during these periods for safety reasons.
  • Major cardiovascular event in the last 3 months — Recent heart attack, stroke, or similar events usually require stabilization first.
Our Approach

Our Process for Determining Your Treatment Plan

01
Initial Consultation
We discuss your weight loss goals, medical history, and concerns to identify the most suitable approach.
02
Cardiac & Health Review
We check your heart health before prescribing — weight-loss treatment should support health, not introduce new risks.
03
Personalized Treatment Plan
A plan tailored to your unique needs, outlining recommended dosing, nutrition, and expected outcomes.
04
Regular Physician Follow-Ups
A physician monitors your progress, reviews side effects, and adjusts your plan as needed throughout treatment.
05
Nutrition & Behavior Support
Medication is only one part of progress. We help with nutrition and behavior changes for steadier, more lasting results.
CardioMender Retatrutide Clinic Pembroke Pines
Why Choose Us

Why Choose CardioMender as Your Retatrutide Clinic?

Weight loss retatrutide isn't something we hand out after a quick chat. At our retatrutide clinic, we check your heart health before prescribing — because weight-loss treatment should support your health, not introduce new risks.

A physician will monitor you with regular follow-ups. We track how you're doing, review side effects, and adjust your plan when needed. Retatrutide is not just a simple prescription; it requires professional medical care.

🫀
Cardiac-First Approach — We review your cardiovascular health before every treatment decision.
🩺
Physician-Only Oversight — A licensed physician manages your entire treatment, not a coordinator.
🥗
Nutrition & Behavior Integration — Medication is paired with lifestyle coaching for sustainable results.
Aesthetic Add-Ons Available — Body contouring and other aesthetic treatments available to complement your journey.
Request a Consultation
Service Areas

Treatment Locations

We serve patients throughout South Florida. Select your nearest location to learn more.

Back To Top